Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
General Information
Revision date
2021-11-04
Product name
GSK1265744B PAEDIATRIC 5 MG DISPERSIBLE TABLET CORES
Product Synonyms
CABOTEGRAVIR * CABOTEGRAVIR SODIUM * GSK1265744B PEDIATRIC 5 MG DISPERSIBLE
1.2.1 Relevant identified uses
Investigational Medicinal Product
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
Physical hazards
Not classified.
Health hazards
Not classified.
Environmental hazards
Hazardous to the aquatic environment, acute Category 2 Hazardous to the aquatic environment, Category 2
Long term hazards
OSHA defined hazards Not classified.
Signal word
None.
Hazard statements
Toxic to aquatic life. Toxic to aquatic life with long lasting effects.
Prevention
Avoid release to the environment.
Response
Collect spillage.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Assume that this material is capable of sustaining combustion.
Classified (HNOC)
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
57.889% of the mixture consists of component(s) of unknown acute oral toxicity. 75.51% of the mixture consists of component(s) of unknown acute dermal toxicity. 60.997% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 60.997% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
